Infectious Agents and Cancer

unofficial impact factor 2.33

This article is part of the supplement: Proceedings of the 11th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI): Basic, Epidemiologic, and Clinical Research

Open Access Oral presentation

Incidence and risk factors of HIV-associated non-Hodgkin-lymophma in the era combined anti-retroviral therapy. A European multi-cohort study

J Bohlius

  • Correspondence: J Bohlius

Infectious Agents and Cancer 2009, 4(Suppl 2):O2 doi:10.1186/1750-9378-4-S2-O2

No comments have yet been made on this article.

Post a comment